cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only

Legal

Terms & research-use-only notice

Research use only

BioRegenEx MSC-derived exosome products are supplied strictly for research use only (RUO). They are not FDA-approved to diagnose, treat, cure, or prevent any disease. Facility registration and a cGMP-aligned process describe a quality approach — they are not FDA approval or endorsement of any product. Any clinical decisions are the sole responsibility of the licensed healthcare provider.

No medical claims

Statements on this website have not been evaluated by the U.S. Food and Drug Administration. Content is provided for informational and research purposes and does not constitute medical advice.

Use of this site

By using this website you agree that content is provided “as is” without warranties of any kind. For supply, documentation, or partnership inquiries, contact info@bioregenex.com.

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.